Merck buys Millipore

DARMSTADT, Germany Merck KGaA plans to buy a Massachusetts life sciences company for $7.2 billion, the German drug maker announced Sunday.

Merck, which is a separate company from U.S.-based Merck & Co., will buy Billerica, Mass.-based Millipore Corp. for $107 per share in a deal approved by the boards of both companies. Merck said the acquisition would create a “world-class partner” for the life sciences sector, allowing it to develop high-margin specialty products.

“This transaction is very attractive to shareholders, customers and employees of both companies,” Merck chairman Karl-Ludwig Kley said in a statement. “This is a combination with an excellent strategic fit, which will allow us to cover the entire value chain for our pharma and biopharma customers, offering integrated solutions beyond chemicals.”

Login or Register to post a comment.